Wockhardt Ltd (WOCKPHARMA)

Company profile

Sector

Pharmaceuticals

Industry

Pharmaceuticals & Biotechnology

Market cap (₹ Cr)

33,525.38

Wockhardt Ltd. engages in the pharmaceutical business. The company is headquartered in Mumbai, Maharashtra and currently employs 2,962 full-time employees. The firm's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. The company manufactures a range of dosage forms, including sterile injectables and lyophilized products. The firm offers products in therapeutic areas of dermatology, cosmeceuticals, oncology, medical nutrition, osteoarthritis, pain management, nephrology, cough therapy and diabetology. The Company’s products across India includes Citawok, Citawok Forte, Citawok Plus, CONSEGNA 30/70 U-200 CART, CONSEGNA R U-200 CART, DARBOTIN PFS, DECDAN, DECDAN B, DECDAN B Injection, DECDAN LITE CREAM, Emrok, Emrok O, Erliso, FOSCHEK-S, Gabawok NT, GLARITUS CART, GLARITUS DISPO, Glimaday, INOGLA, Livatira, GLARITUS CART and VAL 450. The firm has approximately three research centers globally and a chain of six super-specialty hospitals across Maharashtra and Gujarat.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 1,855.5

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E

141.53

52-week high

2,422.3

52-week low

1,086.7

Revenue CAGR, 3 years (%)

8.36

Revenue CAGR, 5 years (%)

4.49

EPS CAGR, 5 years (%)

-22.75

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter

49.08%

FII

7.09%

DII

10.96%

Public

32.83%

Promoter shares pledged

18.83%

Source: finedge · as of 2026-03-31

Similar companies

• Emcure Pharmaceuticals Ltd₹ 36,550.41 Cr
• Sai Life Sciences Ltd₹ 30,046.96 Cr
• Neuland Laboratories Ltd₹ 28,899.32 Cr
• JB Chemicals & Pharmaceuticals Ltd₹ 38,730.77 Cr
• Piramal Pharma Ltd₹ 26,061.14 Cr
• Ajanta Pharma Ltd₹ 42,842.3 Cr

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does Wockhardt Ltd do?

Wockhardt Ltd. engages in the pharmaceutical business. The company is headquartered in Mumbai, Maharashtra and currently employs 2,962 full-time employees. The firm's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. The company manufactures a range of dosage forms, including sterile injectables and lyophilized products. The firm offers products in therapeutic areas of dermatology, cosmeceuticals, oncology, medical nutrition, osteoarthritis, pain management, nephrology, cough therapy and diabetology. The Company’s products across India includes Citawok, Citawok Forte, Citawok Plus, CONSEGNA 30/70 U-200 CART, CONSEGNA R U-200 CART, DARBOTIN PFS, DECDAN, DECDAN B, DECDAN B Injection, DECDAN LITE CREAM, Emrok, Emrok O, Erliso, FOSCHEK-S, Gabawok NT, GLARITUS CART, GLARITUS DISPO, Glimaday, INOGLA, Livatira, GLARITUS CART and VAL 450. The firm has approximately three research centers globally and a chain of six super-specialty hospitals across Maharashtra and Gujarat.

Which sector is Wockhardt Ltd in?

Wockhardt Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.

What are Wockhardt Ltd's latest annual revenue and profit?

For the year ended Mar 2026: revenue 3373.00 Cr, profit after tax 213.00 Cr.

What is the promoter holding and pledge in Wockhardt Ltd?

Promoter holding is 49.08%; pledged shares are 18.83% of the promoter holding.

Which companies are similar to Wockhardt Ltd?

Companies in the same sector of similar size: Emcure Pharmaceuticals Ltd, Sai Life Sciences Ltd, Neuland Laboratories Ltd, JB Chemicals & Pharmaceuticals Ltd, Piramal Pharma Ltd, Ajanta Pharma Ltd.